Negotiations are expected to continue in future cycles as part of President Donald Trump's "aggressive push for lower prices.

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...

The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The federal government’s newly announced savings on 15 expensive prescriptions include the popular Ozempic family of ...

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

The Centers for Medicare & Medicaid Services (CMS) said newly negotiated lower prices for 15 drugs will save 44%, or $12 ...

The agency is able to negotiate some drug prices for Medicare recipients because of a bill signed by former President Joe ...

Price are falling sharply for Medicare beneficiaries prescribed Novo Nordisk’s GLP-1 drugs like Ozempic in 2027.

The United States has revealed price reductions for the second round of | The U.S. has revealed price reductions for the ...

The latest round of Medicare price cuts affect 15 drugs, including Xtandi, an older prostate cancer drug from Pfizer and ...